Barclays Maintains Equal-Weight on Ambev, Lowers Price Target to $2.5
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Benjamin Theurer has maintained an Equal-Weight rating on Ambev (NYSE:ABEV) and lowered the price target from $3 to $2.5.

May 09, 2024 | 2:44 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Barclays has maintained an Equal-Weight rating on Ambev and reduced the price target to $2.5.
The reduction in price target by Barclays, a major financial institution, could lead to a negative short-term sentiment among investors, potentially causing a decrease in Ambev's stock price. The Equal-Weight rating suggests that the stock is expected to perform in line with the market, but the lowered price target indicates a revision of the expected performance level.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100